Wanlu Ma

Wanlu Ma

Auto-generated profile, based on publicly available information

Wanlu Ma

Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Endocrinol, Beijing, Peoples R China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2024 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ZHZhenxing Huang
Zhenxing Huang
XWXi Wang
Xi Wang
BYBingqing Yu
Bingqing Yu
WMWanlu Ma
Wanlu Ma
PZPengyu Zhang
Pengyu Zhang
JMJiangfeng Mao
Jiangfeng Mao
Objective: Both pulsatile gonadotropin-releasing hormone (GnRH) and combined gonadotropin therapy are effective to induce spermatogenesis in men with congenital hypogonadotropic hypogonadism (CHH). This study aimed to evaluate the effect of pulsatile GnRH therapy on spermatogenesis in male patients with CHH who had poor response to combined gonadotropin therapy. Materials and methods: Patients who had poor response to combined gonadotropin therapy ≥ 6 months were recruited and shifted to pulsatile GnRH therapy. The rate of successful spermatogenesis, the median time [...] ABSTRACT Objective: Both pulsatile gonadotropin-releasing hormone (GnRH) and combined gonadotropin therapy are effective to induce spermatogenesis in men with congenital hypogonadotropic hypogonadism (CHH). This study aimed to evaluate the effect of pulsatile GnRH therapy on spermatogenesis in male patients with CHH who had poor response to combined gonadotropin therapy. Materials and methods: Patients who had poor response to combined gonadotropin therapy ≥ 6 months were recruited and shifted to pulsatile GnRH therapy. The rate of successful spermatogenesis, the median time

2 August 2020 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
XYX. Yuan
X. Yuan
WMW. Ma
W. Ma
XWX. Wu
X. Wu
XXX. Xing
X. Xing
YLYuxiu Li
Yuxiu Li
HYHong Yang
Hong Yang

25 February 2021 in Turkish Journal of Hematology
Verified
Journal Article
Open access
WMWanlu Ma
Wanlu Ma
JZJiaWei Zhao
JiaWei Zhao
LZLu Zhang
Lu Zhang

2 June 2021 in Turkish Journal of Hematology
Verified
Journal Article
Open access
WMWanlu Ma
Wanlu Ma
BPBoju Pan
Boju Pan
LZLu Zhang
Lu Zhang

15 July 2025 in Clinics
Verified
Journal Article
Open access
SXShuo Xie
Shuo Xie
LYLiping Yu
Liping Yu
LSLulu Song
Lulu Song
FCFei Chen
Fei Chen
WMWanlu Ma
Wanlu Ma
BZBo Zhang
Bo Zhang
Type 2 Diabetes Mellitus (T2DM) is common worldwide. Patients with T2DM often experience reduced lung function, but the relationship between the two conditions remains uncertain. This study employed Mendelian Randomization (MR) to explore the causal link between T2DM and lung function, and to identify the factors that mediate this relationship. Genome-wide association study data were obtained from public databases. Four glycemic traits were considered exposures, whereas lung function was considered an outcome. Inverse Variance Weighting (IVW) was used to investigate causality, supplemented by MR-Egger and weighted medians methods. Multivariable MR (MVMR) analysis investigated whether T2DM had an independent impact on lung function. Mediation analysis was employed to examine potential mediating impacts. IVW revealed that T2DM was associated with decreased forced expiratory volume in 1s (FEV1) (p = 0.012) and Forced Vital Capacity (FVC) (p = 0.004). After adjusting for potential confounders, the effects of T2DM on FEV1 and FVC remained significant. Mediation analysis demonstrated that smoking and Systolic Blood Pressure (SBP) partially mediated the causal relationship between T2DM, and FEV1 and FVC. The proportions mediated by smoking, SBP, and both factors on FEV1 were 0.302, 0.412, and 0.418, respectively, while the proportion mediated by SBP on FVC was 0.594. This study validated the causal relationship between T2DM and decreased lung function, with smoking and SBP acting as mediators. This study provides a novel perspective on the occurrence and development mechanisms of reduced lung function as well as potential new targets for metabolic intervention in treatment.